Example: dental hygienist
Prothrombin Time Testing - Spectra Laboratories
Oral Anticoagulant - Coumadin Coumadin and other coumarin anticoagulants act by inhibiting the synthesis of vitamin K-dependent clotting factors which include Factors II, V, VII, X and the
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Diagnostic Specimen Collection Guide
www.spectra-labs.comSerum Separator Tube (SST™) 1. Gently invert tube 5-10 times 2. Stand upright in the test tube rack to clot for 30 minutes, no longer than 60 minutes 3. Centrifuge to obtain complete separation 4. Refrigerate (36 º - 46ºF) Order of Draw Tube Remarks Red Top Tube - No Gel (RT) 1. Gently invert tube 5-10 times 2. Refrigerate (36 º - 46ºF)
Kt/V Calculations for the Assessment of …
www.spectra-labs.comSpectra Laboratories, Inc. 525 Sycamore Drive • Milpitas, CA 95035 • 800-433-3773 8 King Road • Rockleigh, NJ 07647 • 800-522-4662 www.spectra-labs.com
References - Spectra Laboratories
www.spectra-labs.comSpectra Laboratories, Inc. 525 Sycamore Drive • Milpitas, CA 95035 • 800-433-3773 8 King Road • Rockleigh, NJ 07647 • 800-522-4662 www.spectra-labs.com
Related documents
Common Blood Collection and Plasma Processing Protocol
wikisites.mcgill.caPage 1 1/10/2008 DRAFT . Common Blood Collection and Plasma Processing Protocol . Clinical Proteomics Technologies Assessment for Cancer (CPTAC) Biospecimen
INTESTINAL PERMEABILITY ASSAY FITC-DEXTRAN - Bowdish
www.bowdish.caFor the pre-test blood, weigh the 1.5mL microfuge tubes containing blood and correct for the pre-determined tube weight to determine the weight of the blood.
New CLSI Coagulation Guidelines: 2009 Update
www.nascola.orgCLSI: Coagulation-focused Guidelines • Four guidelines recently published z Pre-analytical variables z Coagulometer evaluation protocol z PT/APTT testing
Amersham Matrix Metalloproteinase-1, (MMP-1), Biotrak ...
quickzyme.comGE Healthcare Amersham Matrix Metalloproteinase-1, (MMP-1), Biotrak Activity Assay System 96 wells Product Booklet Code: RPN2629
Viral RNA isolation - Macherey-Nagel AG
www.mn-net.com3 Viral RNA isolation MACHEREY-NAGEL – 07 / 2014, Rev. 11 Table of contents 1 Components 4 1.1 Kit contents 4 1.2 Reagents, consumables, and equipment to be supplied by user 6
Cover by D.Meissner WHO/GRA
www.who.intWHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins 2 2 LIST OF ABBREVIATIONS AND DEFINITIONS USED The definitions given below apply to the terms used in these Guidelines.